Chief Executive and President of The Institute of Cancer Research.
Professor Paul Workman FMedSci, FRS is Chief Executive and President of The Institute of Cancer Research (ICR).
Professor Workman is a passionate advocate of personalised molecular medicine and is an enthusiastic practitioner of multidisciplinary cancer drug discovery and development approaches to 'drugging the cancer genome'. He also conceptualised the 'Pharmacological Audit Trail' approach.
See also: Institute of Cancer Research
Paul Workman News
Clinical trials now up for Exscientia's world first AI-made drug
pharmaphorum - 30-Jan-2020
Partnering with Japan's DSP, a milestone is reached in OCD treatmentRead more...
Drug molecule developed using AI to undergo human trials
BBC - 30-Jan-2020
Can speed up drug discovery process using artificial intelligenceRead more...
An effective immunotherapy for advanced prostate cancer
BBC - 28-Nov-2019
Only 5% saw their tumours shrink, but may be more successful if used earlierRead more...
Pembrolizumab: effective immunotherapy for advanced head and neck cancer
BBC - 23-Nov-2019
Needs to identify those who will respond to treatment before starting immunotherapyRead more...
Discovering the structure of cancer molecule can be the key for new treatment
Medical News Today - 16-Sep-2019
By determining the DHX8's structure, scientists could discover new ways of cancer treatmentRead more...